Description: Therapeutic Solutions International, Inc. (TSOI) is focused on immune modulation for the treatment of several specific diseases. TSOI is developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. Its ProJuvenol is a blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality for everyday living, based upon pterostilbene. Its subsidiary, OmniBiome, Inc., is focused on therapeutic/Rx approaches to either utilize or intervene with the systemic effects of the vaginal, lactal-duct and oral microbiomes for improving maternal healthcare and resulting birth outcomes. MolecuVax, Inc. is a subsidiary of the Company. TSOI markets approximately two other nutraceuticals, such as T-Rx, a testosterone booster, and Vital Female, an estrogen booster.
Home Page: www.therapeuticsolutionsint.com
701 Wild Rose Lane
Elk City,
ID
83525
United States
Phone:
760 295 7208
Officers
| Name | Title |
|---|---|
| Mr. Timothy George Dixon | Chairman, CEO & Pres |
| Dr. Feng Lin | Chief Scientific Officer |
| Dr. James Drew Veltmeyer M.D. | Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board |
| Ms. Serena Robella | Director of Sales |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.5523 |
| Price-to-Sales TTM: | 81.7956 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |